Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.
Schubiger
P A
PA
Division of Radiopharmacy, Paul Scherrer Institute, Villigen/PSI, Switzerland.
Alberto
R
R
Smith
A
A
D000906:Antibodies / Q000627:therapeutic use; D002614:Chelating Agents; D005818:Genetic Engineering; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D015394:Molecular Structure; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use*
D000906:Antibodies; D002614:Chelating Agents; D018796:Immunoconjugates; D011868:Radioisotopes